Novartis Vaccines

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 694 490
Fax: +44 (0)1276 698 460
WWW: http://www.novartis.com
Medical Information Direct Line: +44 (0)8457 451 500
Medical Information e-mail: service.uk@novartis.com
Medical Information Fax: +44 (0)1517 055 669

Patient Information Leaflet last updated on the eMC: 20/09/2011
PIL Agrippal Influenza vaccine (surface antigen, inactivated)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
Updated on 06/09/2010 and displayed until 20/09/2011
Reasons for adding or updating:
  • PIL Retired pending re-submission
  • Change of active ingredient
Updated on 01/09/2009 and displayed until 06/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
  • PIL Retired pending re-submission
  • Change of active ingredient
Updated on 29/08/2008 and displayed until 01/09/2009
Reasons for adding or updating:
  • Change of active ingredient
  • Change to date of revision
Updated on 30/10/2007 and displayed until 29/08/2008
Reasons for adding or updating:
  • Change of product licence name
Updated on 19/09/2006 and displayed until 30/10/2007
Reasons for adding or updating:
  • Change to date of revision
  • Change of active ingredient
Updated on 01/11/2005 and displayed until 19/09/2006
Reasons for adding or updating:
  • No reasons supplied
Updated on 24/09/2004 and displayed until 01/11/2005
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 04/08/2003 and displayed until 24/09/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 30/08/2002 and displayed until 04/08/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 08/07/2002 and displayed until 30/08/2002
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   influenza vaccine (surface antigen, inactivated)